A detailed history of Financial Security Advisor, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Security Advisor, Inc. holds 3,764 shares of ABT stock, worth $429,961. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,764
Previous 3,759 0.13%
Holding current value
$429,961
Previous $391 Million 9.87%
% of portfolio
0.11%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.07 - $118.13 $500 - $590
5 Added 0.13%
3,764 $429 Million
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $1,208 - $1,349
12 Added 0.32%
3,759 $391 Million
Q1 2024

Apr 18, 2024

SELL
$109.52 - $120.96 $2,847 - $3,144
-26 Reduced 0.69%
3,747 $426 Million
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $3,697 - $4,526
41 Added 1.1%
3,773 $415 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $356,517 - $427,761
3,732 New
3,732 $361 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Security Advisor, Inc. Portfolio

Follow Financial Security Advisor, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Security Advisor, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Security Advisor, Inc. with notifications on news.